A cervical cancer-free future - First-ever global commitment to eliminate the disease
The world Health Organization’s (WHO) Global Strategy to Accelerate the Elimination of Cervical Cancer has outlined three key steps: vaccination, screening and treatment.
According to the WHO, successful implementation of all three could reduce more than 40 per cent of new cases of the disease and five million related deaths by 2050.
Yesterday’s development represents a historic milestone because it marks the first time that 194 countries commit to eliminating cancer – following adoption of a resolution at this year’s World Health Assembly.
Meeting the following targets by 2030 will place all countries on the path towards elimination:
Ninety per cent of girls fully vaccinated with the HPV vaccine by 15 years of age.
Seventy per cent of women screened using a high-performance test by age 35 and again by 45.
Ninety per cent of women identified with cervical disease receive treatment (90 per cent of women with pre-cancer treated and 90 per cent of women with invasive cancer managed).
The strategy also stresses that investing in the interventions to meet these targets can generate substantial economic and societal returns. An estimated US$3.20 will be returned to the economy for every dollar invested through 2050 and beyond, owing to increases in women’s workforce participation. The figure rises to US$26.00 when the benefits of women’s improved health on families, communities and societies are considered.
“Eliminating any cancer would have once seemed an impossible dream, but we now have the cost-effective, evidence-based tools to make that dream a reality,” said WHO Director General Dr Tedros Adhanom Ghebreyesus. “But we can only eliminate cervical cancer as a public-health problem if we match the power of the tools we have with unrelenting determination to scale up their use globally.”
Cervical cancer is a preventable disease. It is also curable if detected early and adequately treated. Yet it is the fourth most common cancer among women globally. Without taking additional action, the annual number of new cases of cervical cancer is expected to increase from 570,000 to 700,000 between 2018 and 2030, while the annual number of deaths is projected to rise from 311,000 to 400,000. In low- and middle-income countries, its incidence is nearly twice as high and its death rates three times as high as those in high-income countries.
“The huge burden of mortality related to cervical cancer is a consequence of decades of neglect by the global health community. However, the script can be rewritten,” says WHO Assistant Director General Dr Princess Nothemba (Nono) Simelela. “Critical developments include the availability of prophylactic vaccines; low-cost approaches to screening and treating cervical cancer precursors; and novel approaches to surgical training. Through a shared global commitment to the Sustainable Development Goals and leaving no one behind, the countries of the world are forging a new path to ending cervical cancer.”
The strategy is launched at a challenging time, however.
The COVID-19 pandemic has posed challenges to preventing deaths due to cancer, including the interruption of vaccination, screening and treatment services; border closures that reduced the availability of supplies and that prevent the transit of skilled biomedical engineers to maintain equipment; new barriers preventing women in rural areas from travelling to referral centres for treatment; and school closures that interrupt school vaccine programmes. To the extent possible, however, WHO urges all countries to ensure that vaccination, screening and treatment can continue safely, with all necessary precautions.
“The fight against cervical cancer is also a fight for women’s rights: the unnecessary suffering caused by this preventable disease reflects the injustices that uniquely affect women’s health around the world,” says Dr Princess Nothemba Simelela. “Together, we can make history to ensure a cervical cancer-free future.”